Showing 1 - 4 of 4 Results

This lecture series was formed to enhance opportunities for dialogue about how innovations in genomics research and technology can impact health disparities. Topics range from basic science to translational research.

Format: In Person , Online
Dates: Beginning March 25, 2017
Length: 1 Hour
Eligibility: Open to the Public
Offered by: National Human Genome Research Institute (NHGRI), National Heart, Lung and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Minority Health and Health Disparities (NIMHD), and the Office of Minority Health at the Food and Drug Administration (FDA)

The NIH-Duke Master's Program in Clinical Research, established in 1998, is one of the nation's first training programs in clinical research. This program allows participants to attend formal courses in research design, research management, medical genomics, and statistical analysis at the Clinical Center by means of video-conferencing from Duke or on-site by adjunct faculty.

The program leads to a Master of Health Sciences in Clinical Research, a professional degree awarded by the Duke University School of Medicine. There is also a non-degree option for qualified students who want to pursue specific areas of interest.

Applications will be accepted through August 1, 2020.

Format: In Person
Dates: Offered Annually
Offered by: National Institutes of Health (NIH) and Duke University

The objective of this course is to provide a thorough grounding in the conduct of randomized clinical trials to researchers and health professionals interested in developing competence in the planning, design, and execution of randomized clinical trials involving behavioral interventions. 

The curriculum will enable participants to:

  • Describe the principles underlying the conduct of unbiased clinical trials
  • Identify the unique challenges posed by behavioral randomized clinical trials (RCTs)
  • Evaluate RCT designs in terms of their appropriateness to scientific and clinical goals
  • Select appropriate strategies for enrollment, randomization, and retention of participants
  • Understand methods for monitoring, coordinating, and conducting RCTs
  • Develop strategies for appropriate statistical analyses of RCT data
  • Evaluate the quality of behavioral RCTs and interpret their results
  • Design an RCT as part of a working group on a specific topic.
Format: In Person
Dates: Annually (Check Website for Application Deadline)
Eligibility: Open to the Public
Offered by: NIH Office of Behavioral and Social Sciences Research (OBSSR) and National Heart, Lung, and Blood Institute (NHLBI)

The National Cancer Institute is hosting this training institute to provide participants with a thorough grounding in conducting D&I research with a specific focus on cancer, across the cancer control continuum. In 2020, the institute will use a combination of online coursework (six modules with related assignments) and a 2-day in-person training to be held August 3 and 4, 2020, at the NCI campus in Bethesda, MD. Faculty and guest lecturers consist of leading experts in D&I theories, models, and frameworks; intervention fidelity and adaptation; stakeholder engagement and partnership for D&I; research methods and study designs for D&I; and measures and outcomes for D&I. This training institute has been adapted from the broader Training Institute for Dissemination and Implementation Research in Health (TIDIRH), organized by NIH and the VA over the past nine years.

This training is designed for investigators at any career stage interested in conducting D&I research with a focus on the cancer control continuum. There is no cost associated with the training. Invited participants are required to cover related travel expenses to the Washington D.C. area for the in-person meeting. More answers to common questions can be found on the site FAQ.

Format: In Person , Online
Dates: Annually (Check Course Website for Current Dates)
Length: Combination Online Course and 2-Day In-person Training
Eligibility: Open to the Public
Offered by: National Cancer Institute (NCI)